Position in ALKS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$61,320,679
+$54,866,244 QoQ
Shares Held
1,170,242
+541.1% QoQ
Ownership
0.698%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#32
of 423 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $845,206,958 across 34 Drug Manufacturers - Specialty & Generic names. ALKS ranks #6 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
340,275 | $184,371,197 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
3,316,358 | $136,070,166 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
553,068 | $93,214,076 | |
| 4 | VTRS |
Viatris Inc
|
5,658,439 | $89,856,006 | |
| 5 | ZTS |
Zoetis Inc.
|
912,367 | $65,562,688 | |
| 6 | ALKS |
Alkermes plc.
This page
|
1,170,242 | $61,320,679 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
2,950,225 | $52,986,040 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
2,844,583 | $41,218,006 |
All Filings in ALKS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,320,679 | 1,170,242 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,454,435 | 182,535 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,394,736 | 192,807 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $5,530,380 | 184,346 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,689,651 | 94,011 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $3,104,142 | 94,008 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,787,531 | 96,924 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,358,964 | 120,006 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $2,822,180 | 117,103 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,133,842 | 226,592 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,015,086 | 144,740 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $4,433,141 | 158,270 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,273,078 | 168,469 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,454,728 | 87,078 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,271,923 | 86,947 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,929,377 | 86,403 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,032,073 | 34,645 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,115,174 | 42,386 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $824,217 | 35,435 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $931,891 | 30,217 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||